TOKYO, Aug. 2, 2022 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced the following changes to its management structure effective October 1, 2022. 1. Top Management Appointment of new CMO Dr. Tadaaki Taniguchi, MD, Ph.D,…